Mrs Carrie Ellen Theiss, LPN | |
2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131 | |
(410) 278-1928 | |
(410) 278-1944 |
Full Name | Mrs Carrie Ellen Theiss |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 2501 Oakington St, Aberdeen Proving Ground, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326197427 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 26NP05500300 (New Jersey) | Primary |
164X00000X | Licensed Vocational Nurse | 189425 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Carrie Ellen Theiss, LPN 2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131 Ph: (410) 278-1928 | Mrs Carrie Ellen Theiss, LPN 2501 Oakington St, Aberdeen Proving Ground, MD 21005-5131 Ph: (410) 278-1928 |
News Archive
Porvair Sciences announces a new easy-to-use 96-well Supported Liquid Extraction (SLE) microplate designed for high recovery extraction of analytes from biological fluids. Using the Porvair SLE plate high analyte recovery, free of proteins and phospholipids, is routinely obtainable without the need for offline steps such as protein precipitation.
Members of the Medicare Payment Advisory Commission on Thursday will testify before House and Senate committees with jurisdiction over Medicare about their annual report, which likely will include recommendations on revisions to the Medicare physician reimbursement formula, the Palm Beach Post reports.
Odds are, there-s a virus living inside your gut that has gone undetected by scientists for decades. A new study led by researchers at San Diego State University has found that more than half the world-s population is host to a newly described virus, named crAssphage, which infects one of the most common types of gut bacteria, Bacteroidetes.
Forest Laboratories, Inc. and Gedeon Richter Plc today announced positive top-line results from a Phase IIb clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of acute exacerbation of schizophrenia.
› Verified 5 days ago